US Stock MarketDetailed Quotes

INZY Inozyme Pharma

Watchlist
  • 4.360
  • +0.070+1.63%
Close Nov 1 16:00 ET
  • 4.360
  • 0.0000.00%
Post 20:01 ET
292.55MMarket Cap-3027P/E (TTM)

About Inozyme Pharma Company

Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company. It engages in the business of developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company was founded by Axel Bolte, Joseph P. Schlessinger, and Demetrios T. Braddock in September 2015 and is headquartered in Boston, MA.

Company Profile

SymbolINZY
Company NameInozyme Pharma
Listing DateJul 24, 2020
Issue Price16.00
Founded2015
CEODr. Douglas A. Treco, PhD
MarketNASDAQ
Employees59
Fiscal Year Ends12-31
Address321 Summer Street,Suite 400
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02210
Phone1-857-330-4340
Websitehttp://www.inozyme.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Douglas A. Treco, PhD
  • Chairman of the Board and Chief Executive Officer
  • 5.30M
  • Sanjay Subramanian
  • Chief Financial Officer, Principal Accounting Officer and Corporate Secretary
  • 1.03M
  • Matthew Winton
  • Chief Operations Officer
  • 1.55M
  • Axel Bolte
  • Director
  • 1.80M
  • Erik Harris
  • Director
  • --
  • Dr. Robert Hopfner, M.B.A.,PhD,R.Ph.
  • Independent Director
  • 112.15K
  • Lynne Sullivan
  • Independent Director
  • 122.15K
  • Dr. Martin William Edwards, M.D.
  • Independent Director
  • 129.65K
  • Edward T. Mathers
  • Independent Director
  • 116.15K
  • Dr. Sarah Bhagat, PhD
  • Independent Director
  • 114.65K
  • Reinaldo M. Diaz
  • Lead Independent Director
  • 130.27K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data